Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 30Oropharyngeal Neoplasms 21Nasopharyngeal Carcinoma 15Head and Neck Neoplasms 13Prostatic Neoplasms 11Laryngeal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Carcinoma, Squamous Cell 8Carcinoma 8Breast Neoplasms 8Rectal Neoplasms 7Mouth Neoplasms 7Hypopharyngeal Neoplasms 7Glioma 6Glioblastoma 6Uterine Cervical Neoplasms 5Papillomavirus Infections 5Esophageal Neoplasms 5Urinary Bladder Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Nasopharyngeal Neoplasms 4Astrocytoma 4Mesothelioma, Malignant 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Endometrial Neoplasms 3Brain Neoplasms 3Tumor Virus Infections 2Tongue Neoplasms 2Thyroid Carcinoma, Anaplastic 2

Interventions

Temozolomide 3Cyclophosphamide 3fludarabine phosphate 2Vincristine 2PM 01183 2Irinotecan 2Ifosfamide 2Etoposide 2Doxorubicin 2thymoglobulin 1temsirolimus 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1fludarabine 1Zoledronic Acid 1Vinorelbine 1Thiotepa 1Tacrolimus 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Sorafenib 1Ramucirumab 1Radiotherapy, Intensity-Modulated 1Radiation 1Proton Therapy 1Mycophenolic Acid 1Mesna 1Melphalan 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Desmoplastic Small Round Cell Tumor × Radiotherapy, Intensity-Modulated × 1 year × Clear all
NCT04022213 2025-07-20

A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
31 enrolled

Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡